Manipulating human dendritic cell phenotype and function with targeted porous silicon nanoparticles

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Dendritic cells (DCs) are crucial for transplant tolerance due to their antigen-presenting capabilities.
• The DC-SIGN receptor presents a therapeutic target for modulating DC activity.
• Porous silicon (pSi) nanoparticles offer a biodegradable platform for targeted drug delivery.

Purpose of the Study:

• To fabricate and characterize rapamycin-loaded pSi nanoparticles displaying anti-DC-SIGN antibodies.
• To evaluate the uptake efficiency of these nanoparticles by DCs.
• To assess the impact of these nanoparticles on DC phenotype, function, and T-cell proliferation.

Main Methods:

• Fabrication of rapamycin-loaded pSi nanoparticles functionalized with anti-DC-SIGN antibodies.
• Assessment of nanoparticle uptake by monocyte-derived and myeloid DCs in whole human blood.
• Analysis of DC phenotype and function post-nanoparticle treatment.
• Evaluation of nanoparticle-mediated suppression of allogeneic T-cell proliferation.

Main Results:

• pSi nanoparticles functionalized with anti-DC-SIGN antibodies were efficiently phagocytosed by DCs in a time- and dose-dependent manner.
• DC preconditioning with rapamycin-loaded nanoparticles induced a maturation-resistant phenotype.
• Allogeneic T-cell proliferation was significantly suppressed following DC treatment with the nanoparticles.

Conclusions:

• Rapamycin-loaded, DC-SIGN targeting pSi nanoparticles represent a viable platform for modifying dendritic cells.
• This approach shows potential for enhancing transplant tolerance by suppressing T-cell responses.